67 research outputs found
Ductal prostate cancer: Clinical features and outcomes from a multicenter retrospective analysis and overview of the current literature
Dyspnea in Patients Receiving Radical Radiotherapy for Non-Small Cell Lung Cancer: A Prospective Study
Background and Purpose: Dyspnea is an important symptomatic endpoint for
assessment of radiation-induced lung injury (RILI) following radical radiotherapy in
locally advanced disease, which remains the mainstay of treatment at the time of
significant advances in therapy including combination treatments with immunotherapy
and chemotherapy and the use of local ablative radiotherapy techniques. We investigated
the relationship between dose-volume parameters and subjective changes in dyspnea as
a measure of RILI and the relationship to spirometry.
Material and Methods: Eighty patients receiving radical radiotherapy for non-small cell
lung cancer were prospectively assessed for dyspnea using two patient-completed tools:
EORTC QLQ-LC13 dyspnea quality of life assessment and dyspnea visual analogue scale
(VAS). Global quality of life, spirometry and radiation pneumonitis grade were also
assessed. Comparisons were made with lung dose-volume parameters.
Results: The median survival of the cohort was 26 months. In the evaluable group of 59
patients there were positive correlations between lung dose-volume parameters and a
change in dyspnea quality of life scale at 3 months (V30 p=0.017; V40 p=0.026; V50
p=0.049; mean lung dose p=0.05), and a change in dyspnea VAS at 6 months (V30
p=0.05; V40 p=0.026; V50 p=0.028) after radiotherapy. Lung dose-volume parameters
predicted a 10% increase in dyspnea quality of life score at 3 months (V40; p=0.041, V50;
p=0.037) and dyspnea VAS score at 6 months (V40; p=0.027) post-treatment.
Conclusions: Worsening of dyspnea is an important symptom of RILI. We demonstrate a
relationship between lung dose-volume parameters and a 10% worsening of subjectiv
The Role of Multiparametric Magnetic Resonance in Volumetric Modulated Arc Radiation Therapy Planning for Prostate Cancer Recurrence After Radical Prostatectomy: A Pilot Study
Background and Purpose: Volumetric modulated arc radiotherapy (RT) has become pivotal in the treatment of prostate cancer recurrence (RPC) to optimize dose distribution and minimize toxicity, thanks to the high-precision delineation of prostate bed contours and organs at risk (OARs) under multiparametric magnetic resonance (mpMRI) guidance. We aimed to assess the role of pre-treatment mpMRI in ensuring target volume coverage and normal tissue sparing.
Material and Methods: Patients with post-prostatectomy RPC eligible for salvage RT were prospectively recruited to this pilot study. Image registration between planning CT scan and T2w pre-treatment mpMRI was performed. Two sets of volumes were outlined, and DWI images/ADC maps were used to facilitate precise gross tumor volume (GTV) delineation on morphological MRI scans. Two rival plans (mpMRI-based or not) were drawn up.
Results: Ten patients with evidence of RPC after prostatectomy were eligible. Preliminary data showed lower mpMRI-based clinical target volumes than CT-based RT planning (p = 0.0003): median volume difference 17.5 cm3. There were no differences in the boost volume coverage nor the dose delivered to the femoral heads and penile bulb, but median rectal and bladder V70Gy was 4% less (p = 0.005 and p = 0.210, respectively) for mpMRI-based segmentation.
Conclusions: mpMRI provides high-precision target delineation and improves the accuracy of RT planning for post-prostatectomy RPC, ensures better volume coverage with better OARs sparing and allows non-homogeneous dose distribution, with an aggressive dose escalation to the GTV. Randomized phase III trials and wider datasets are needed to fully assess the role of mpMRI in optimizing therapeutic strategies
Impact of gastrointestinal side effects on patients’ reported quality of life trajectories after radiotherapy for prostate cancer: Data from the prospective, observational pros-it CNR study
Radiotherapy (RT) represents an important therapeutic option for the treatment of localized prostate cancer. The aim of the current study is to examine trajectories in patients’ reported quality of life (QoL) aspects related to bowel function and bother, considering data from the PROState cancer monitoring in ITaly from the National Research Council (Pros-IT CNR) study, analyzed with growth mixture models. Data for patients who underwent RT, either associated or not associated with androgen deprivation therapy, were considered. QoL outcomes were assessed over a 2-year period from the diagnosis, using the Italian version of the University of California Los Angeles-Prostate Cancer Index (Italian-UCLA-PCI). Three trajectories were identified for the bowel function; having three or more comorbidities and the use of 3D-CRT technique for RT were associated with the worst trajectory (OR = 3.80, 95% CI 2.04–7.08; OR = 2.17, 95% CI 1.22–3.87, respectively). Two trajectories were identified for the bowel bother scores; diabetes and the non-Image guided RT method were associated with being in the worst bowel bother trajectory group (OR = 1.69, 95% CI 1.06–2.67; OR = 2.57, 95% CI 1.70–3.86, respectively). The findings from this study suggest that the absence of comorbidities and the use of intensity modulated RT techniques with image guidance are related with a better tolerance to RT in terms of bowel side effects
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study
Background: The National Research Council (CNR) prostate cancer monitoring project in Italy (Pros-IT CNR) is an observational, prospective, ongoing, multicentre study aiming to monitor a sample of Italian males diagnosed as new cases of prostate cancer. The present study aims to present data on the quality of life at time prostate cancer is diagnosed. Methods: One thousand seven hundred five patients were enrolled. Quality of life is evaluated at the time cancer was diagnosed and at subsequent assessments via the Italian version of the University of California Los Angeles-Prostate Cancer Index (UCLA-PCI) and the Short Form Health Survey (SF-12). Results: At diagnosis, lower scores on the physical component of the SF-12 were associated to older ages, obesity and the presence of 3+ moderate/severe comorbidities. Lower scores on the mental component were associated to younger ages, the presence of 3+ moderate/severe comorbidities and a T-score higher than one. Urinary and bowel functions according to UCLA-PCI were generally good. Almost 5% of the sample reported using at least one safety pad daily to control urinary loss; less than 3% reported moderate/severe problems attributable to bowel functions, and sexual function was a moderate/severe problem for 26.7%. Diabetes, 3+ moderate/severe comorbidities, T2 or T3-T4 categories and a Gleason score of eight or more were significantly associated with lower sexual function scores at diagnosis. Conclusions: Data collected by the Pros-IT CNR study have clarified the baseline status of newly diagnosed prostate cancer patients. A comprehensive assessment of quality of life will allow to objectively evaluate outcomes of different profile of care
Early warning of systemic risk in global banking: eigen-pair R number for financial contagion and market price-based methods
We analyse systemic risk in the core global banking system using a new network-based spectral eigen-pair method, which treats network failure as a dynamical system stability problem. This is compared with market price-based Systemic Risk Indexes, viz. Marginal Expected Shortfall, Delta Conditional Value-at-Risk, and Conditional Capital Shortfall Measure of Systemic Risk in a cross-border setting. Unlike paradoxical market price based risk measures, which underestimate risk during periods of asset price booms, the eigen-pair method based on bilateral balance sheet data gives early-warning of instability in terms of the tipping point that is analogous to the R number in epidemic models. For this regulatory capital thresholds are used. Furthermore, network centrality measures identify systemically important and vulnerable banking systems. Market price-based SRIs are contemporaneous with the crisis and they are found to covary with risk measures like VaR and betas
Pulmonary epithelioid hemangioendothelioma presenting with vertebral metastases: a case report.”
Introduction: Epithelioid hemangioendothelioma is a rare vascular tumor that has an epithelioid and histiocytoid
appearance, originates from vascular endothelial or pre-endothelial cells and comprises less than 1% of all vascular
tumors. It was described for the first time in 1975 as pulmonary epithelioid hemangioendothelioma, because initially
it was believed to be an aggressive form of bronchoalveolar cell carcinoma with a remarkable propensity to
invade adjacent blood vessels and small airways. Only a few cases have been reported in the literature to date.
Tumor cells expressing Fli-1 and CD31 have been identified as relatively specific endothelial markers. Epithelioid
hemangioendothelioma may affect multiple organs and may vary considerably in its clinical and radiological
presentation. More than 50% to 76% of pulmonary epithelioid hemangioendothelioma patients are asymptomatic.
They are usually incidentally diagnosed on the basis of abnormal chest radiography during routine physical examinations.
Hematologic and gastrointestinal disorders and weakness or numbness may also be observed, in addition to respiratory
symptoms, in cases of disseminated pulmonary epithelioid hemangioendothelioma. Pain and swelling, pathological
fractures, spine compression or paresthesia, loss of muscular strength and paraplegia may be present when bone
metastases occur. Because of the rarity of this disease, there is no standard for treatment.
Case presentation: A 46-year-old Caucasian woman presented to our institution in November 2009 with metastases
of pulmonary epithelioid hemangioendothelioma from the L3 and L4 vertebrae. A course of radiotherapy at a dosage
of 3,000cGy delivered in individual doses of 200cGy/day for 5 days/wk to the L3 and L4 vertebrae led to the
disappearance of the patient’s lumbar pain without any detectable side effects. Percussion of the patient’s vertebral
spine was negative, and no radiological progression of bone disease was found at her 1-year follow-up examination.
Conclusion: Since epithelioid hemangioendothelioma was first correctly defined, several research groups have
reported their experiences with epithelioid hemangioendothelioma irradiation. Further studies are needed to establish
a standard radiation dose to be used for such a complex and extremely rare disease. In our present case, a
radiotherapy dosage of 3,000cGy delivered in individual doses 200cGy/day for 5 days/wk allowed us to reach our goals:
local pain control with good tolerance and better quality of life by the 1-year follow-up examination
[A new method of functional rehabilitation of patients with occupational disability caused by lumbar spine pathology].
Rehabilitation is reducing disability through an improvement of function, i.e. rehabilitation need always to be "functional". Nevertheless, like it happened in other fields where rehabilitation has not yet reached its maturity, in spinal pathologies it has usually been considered equal to conservative treatment, i.e. not surgical relief of pain. But relieving pain does not always mean to recover function: in fact, it has been proven that there are no long term good results treating symptomatically chronic low back pain (CLBP). In the Eighties in USA a new kind of treatment has been introduced for inpatient rehabilitation of CLBP, based on a full-time four-weeks training of physical abilities, together with a cognitive and educational approach to pain. This treatment, named "functional rehabilitation", proved its efficacy also in randomised controlled trials (RCT). In the Nineties in Finland the outpatient version of this treatment for CLBP has been developed by "Documentation Based Care" (DBC), whose efficacy have also been documented in RCT: the efficiency of this last kind of treatment should be higher. DBC treatment is spreading around the world, and it recently reached Italy in Don Gnocchi
A multiplex financial network approach to policy evaluation: the case of euro area Quantitative Easing
- …